KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Alnylam Pharmaceuticals (ALNY) over the last 17 years, with Q3 2025 value amounting to -$12.5 million.

  • Alnylam Pharmaceuticals' Other Working Capital Changes fell 30063.9% to -$12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$65.8 million, marking a year-over-year increase of 6791.85%. This contributed to the annual value of -$235.4 million for FY2024, which is 52791.25% down from last year.
  • As of Q3 2025, Alnylam Pharmaceuticals' Other Working Capital Changes stood at -$12.5 million, which was down 30063.9% from -$73.2 million recorded in Q2 2025.
  • In the past 5 years, Alnylam Pharmaceuticals' Other Working Capital Changes registered a high of $75.5 million during Q1 2024, and its lowest value of -$295.0 million during Q2 2024.
  • For the 5-year period, Alnylam Pharmaceuticals' Other Working Capital Changes averaged around -$18.4 million, with its median value being -$3.1 million (2024).
  • Per our database at Business Quant, Alnylam Pharmaceuticals' Other Working Capital Changes crashed by 126723.43% in 2022 and then skyrocketed by 68830.59% in 2024.
  • Alnylam Pharmaceuticals' Other Working Capital Changes (Quarter) stood at $9.7 million in 2021, then crashed by 1267.23% to -$113.1 million in 2022, then surged by 115.64% to $17.7 million in 2023, then crashed by 172.42% to -$12.8 million in 2024, then grew by 2.11% to -$12.5 million in 2025.
  • Its last three reported values are -$12.5 million in Q3 2025, -$73.2 million for Q2 2025, and $32.8 million during Q1 2025.